FARAH NASRATY
Prescription History 1104244813
Internal Medicine - Hematology & Oncology in La Jolla, CA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for FARAH NASRATY, an active Hematology & Oncology specialist practicing in La Jolla, CA. Our medical registry currently tracks 20 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,256 documented patient claims. Among these therapy options, the most frequently utilized medication is Anastrozole, which accounts for 631 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other CA PrescribersVs. CA Avg |
|---|---|---|---|
| Anastrozole | 631 | $29.70 | ▲ More than typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2023, this provider wrote 631 Medicare prescriptions for Anastrozole, about 9.3 times the volume of the typical California prescriber of this medication (68). Medicare paid an average of $29.70 per fill, versus $27.13 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 1,524.6 30-Day Fills standardized to 30-day supplies 45,665 Days of Medication total across all patients in 2023 | |||
| Letrozole | 151 | $42.44 | ▲ More than typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2023, this provider wrote 151 Medicare prescriptions for Letrozole, about 3.1 times the volume of the typical California prescriber of this medication (48). Medicare paid an average of $42.44 per fill, versus $32.45 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 348.4 30-Day Fills standardized to 30-day supplies 10,365 Days of Medication total across all patients in 2023 | |||
| Exemestane | 76 | $204.94▼ below CA avg | ▲ More than typical |
About Exemestane: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. Exemestane is usually not used in women of childbearing age. In 2023, this provider wrote 76 Medicare prescriptions for Exemestane, about 2.8 times the volume of the typical California prescriber of this medication (27). Medicare paid an average of $204.94 per fill, versus $259.64 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 165 30-Day Fills standardized to 30-day supplies 4,935 Days of Medication total across all patients in 2023 | |||
| Tamoxifen Citrate | 54 | $35.98▼ below CA avg | ▲ More than typical |
About Tamoxifen Citrate: Tamoxifen is used to treat breast cancer. Show more ▾ It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue. One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. In 2023, this provider wrote 54 Medicare prescriptions for Tamoxifen Citrate, about 1.6 times the volume of the typical California prescriber of this medication (34). Medicare paid an average of $35.98 per fill, versus $36.55 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 127 30-Day Fills standardized to 30-day supplies 3,810 Days of Medication total across all patients in 2023 | |||
| Prochlorperazine Maleate | 44 | $21.68 | ▲ More than typical |
About Prochlorperazine Maleate: This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Show more ▾ Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery. A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612) In 2023, this provider wrote 44 Medicare prescriptions for Prochlorperazine Maleate, about 1.6 times the volume of the typical California prescriber of this medication (28). Medicare paid an average of $21.68 per fill, versus $18.29 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 44 30-Day Fills standardized to 30-day supplies 614 Days of Medication total across all patients in 2023 | |||
| Dexamethasone | 36 | $15.95▼ below CA avg | ≈ Typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2023, this provider wrote 36 Medicare prescriptions for Dexamethasone, about the same volume as the typical California prescriber of this medication (32). Medicare paid an average of $15.95 per fill, versus $19.76 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 36 30-Day Fills standardized to 30-day supplies 361 Days of Medication total across all patients in 2023 | |||
| ProliaDenosumab | 35 | $1,541.38 | ≈ Typical |
About Prolia: Denosumab is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases after menopause (in women), as you age, if someone in your family has osteoporosis, or if you take certain medications (such as prednisone) for long periods. This medication works by slowing bone loss to help maintain strong bones and reduce the risk of broken bones (fractures). Denosumab belongs to a class of drugs called monoclonal antibodies. It prevents certain cells in the body (osteoclasts) from breaking down bone. A humanized monoclonal antibody and an inhibitor of the RANK LIGAND, which regulates OSTEOCLAST differentiation and bone remodeling. It is used as a BONE DENSITY CONSERVATION AGENT in the treatment of OSTEOPOROSIS. In 2023, this provider wrote 35 Medicare prescriptions for Prolia, about 90% of the volume of the typical California prescriber of this medication (39). Medicare paid an average of $1,541.38 per fill, versus $1,523.14 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 210 30-Day Fills standardized to 30-day supplies 6,300 Days of Medication total across all patients in 2023 | |||
| LynparzaOlaparib | 34 | $10,912.11▼ below CA avg | ▲ More than typical |
About Lynparza: This medication is used to treat certain cancers (such as breast, ovarian, fallopian tube, pancreatic, peritoneal cancer, prostate). Show more ▾ Olaparib works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 34 Medicare prescriptions for Lynparza, about 1.9 times the volume of the typical California prescriber of this medication (18). Medicare paid an average of $10,912.11 per fill, versus $13,776.11 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 34 30-Day Fills standardized to 30-day supplies 1,020 Days of Medication total across all patients in 2023 | |||
| Gabapentin | 23 | $5.87▼ below CA avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2023, this provider wrote 23 Medicare prescriptions for Gabapentin, about a third of the volume of the typical California prescriber of this medication (81). Medicare paid an average of $5.87 per fill, versus $21.28 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 40.5 30-Day Fills standardized to 30-day supplies 1,143 Days of Medication total across all patients in 2023 | |||
| Lidocaine-PrilocaineLidocaine/Prilocaine | 22 | $14.19▼ below CA avg | ≈ Typical |
About Lidocaine-Prilocaine: This medication contains 2 amide-type local anesthetics, lidocaine and prilocaine. Show more ▾ It is used on normal, unbroken skin or on the outer genital area to prevent pain before certain procedures such as inserting a needle, skin grafts, or skin laser surgery. It works by temporarily numbing the skin and surrounding area. Do not use this product in the ears. If this product alone cannot completely numb the area being treated, it may be used to numb the area before a lidocaine injection is given to provide enough pain relief for certain procedures (such as removal of genital warts). A topical local anesthetic preparation that is composed of a mixture of lidocaine and prilocaine. It is used to provide anesthesia during minor surgery and for the treatment of PREMATURE EJACULATION. In 2023, this provider wrote 22 Medicare prescriptions for Lidocaine-Prilocaine, about the same volume as the typical California prescriber of this medication (23). Medicare paid an average of $14.19 per fill, versus $26.54 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 22 30-Day Fills standardized to 30-day supplies 615 Days of Medication total across all patients in 2023 | |||
| Ondansetron Hcl | 22 | $10.10 | ▼ Less than typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. In 2023, this provider wrote 22 Medicare prescriptions for Ondansetron Hcl, about 73% of the volume of the typical California prescriber of this medication (30). Medicare paid an average of $10.10 per fill, versus $8.60 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 435 Days of Medication total across all patients in 2023 | |||
| Venlafaxine Hcl ErVenlafaxine Hcl | 21 | $27.49▼ below CA avg | ▼ Less than typical |
About Venlafaxine Hcl Er: Venlafaxine is used to treat depression, anxiety, panic attacks, and social anxiety disorder (social phobia). Show more ▾ It may improve your mood and energy level and may help restore your interest in daily living. It may also decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. Venlafaxine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain. In 2023, this provider wrote 21 Medicare prescriptions for Venlafaxine Hcl Er, about 72% of the volume of the typical California prescriber of this medication (29). Medicare paid an average of $27.49 per fill, versus $30.98 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 56.5 30-Day Fills standardized to 30-day supplies 1,696 Days of Medication total across all patients in 2023 | |||
| EliquisApixaban | 16 | $889.79 | ▼ Less than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. In 2023, this provider wrote 16 Medicare prescriptions for Eliquis, about a quarter of the volume of the typical California prescriber of this medication (68). Medicare paid an average of $889.79 per fill, versus $848.49 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23 30-Day Fills standardized to 30-day supplies 690 Days of Medication total across all patients in 2023 | |||
| Lorazepam | 15 | $4.58▼ below CA avg | ▼ Less than typical |
About Lorazepam: This medication is used to treat serious seizures that do not stop (status epilepticus). Show more ▾ It is also used before surgeries or procedures to cause drowsiness, decrease anxiety, and cause forgetfulness about the procedure or surgery. Lorazepam belongs to a class of medications called benzodiazepines, which produce a calming effect on the brain and nerves (central nervous system). It is thought to work by increasing the effect of a certain natural chemical (GABA) in the brain. A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. In 2023, this provider wrote 15 Medicare prescriptions for Lorazepam, about a third of the volume of the typical California prescriber of this medication (45). Medicare paid an average of $4.58 per fill, versus $7.40 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 15 30-Day Fills standardized to 30-day supplies 219 Days of Medication total across all patients in 2023 | |||
| XgevaDenosumab | 15 | $3,109.49 | ▼ Less than typical |
About Xgeva: Denosumab is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases after menopause (in women), as you age, if someone in your family has osteoporosis, or if you take certain medications (such as prednisone) for long periods. This medication works by slowing bone loss to help maintain strong bones and reduce the risk of broken bones (fractures). Denosumab belongs to a class of drugs called monoclonal antibodies. It prevents certain cells in the body (osteoclasts) from breaking down bone. A humanized monoclonal antibody and an inhibitor of the RANK LIGAND, which regulates OSTEOCLAST differentiation and bone remodeling. It is used as a BONE DENSITY CONSERVATION AGENT in the treatment of OSTEOPOROSIS. In 2023, this provider wrote 15 Medicare prescriptions for Xgeva, about half the volume of the typical California prescriber of this medication (32). Medicare paid an average of $3,109.49 per fill, versus $2,874.33 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 420 Days of Medication total across all patients in 2023 | |||
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 14 | $8.32▼ below CA avg | ▼ Less than typical |
About Diphenoxylate-Atropine: This medication is used to treat diarrhea. Show more ▾ It helps to decrease the number and frequency of bowel movements. It works by slowing the movement of the intestines. Diphenoxylate is similar to opioid pain relievers, but it acts mainly to slow the gut. Atropine belongs to a class of drugs known as anticholinergics, which help to dry up body fluids and also slow gut movement. This medication should not be used to treat diarrhea caused by certain types of infection (such as C. difficile-associated diarrhea following antibiotic therapy). Talk to your doctor for more details. This medication is not recommended for use in children younger than 6 years due to an increased risk of serious side effects (such as breathing problems). In 2023, this provider wrote 14 Medicare prescriptions for Diphenoxylate-Atropine, about 70% of the volume of the typical California prescriber of this medication (20). Medicare paid an average of $8.32 per fill, versus $31.55 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 14 30-Day Fills standardized to 30-day supplies 126 Days of Medication total across all patients in 2023 | |||
| Pantoprazole Sodium | 12 | $9.51▼ below CA avg | ▼ Less than typical |
About Pantoprazole Sodium: Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). Show more ▾ It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER. In 2023, this provider wrote 12 Medicare prescriptions for Pantoprazole Sodium, about 19% of the volume of the typical California prescriber of this medication (62). Medicare paid an average of $9.51 per fill, versus $16.94 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 12 30-Day Fills standardized to 30-day supplies 352 Days of Medication total across all patients in 2023 | |||
| IbrancePalbociclib | 12 | $15,843.09 | ▼ Less than typical |
About Ibrance: Palbociclib is used to treat a certain type of breast cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 12 Medicare prescriptions for Ibrance, about half the volume of the typical California prescriber of this medication (28). Medicare paid an average of $15,843.09 per fill, versus $14,455.37 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13.5 30-Day Fills standardized to 30-day supplies 399 Days of Medication total across all patients in 2023 | |||
| VerzenioAbemaciclib | 12 | $16,855.03 | ▼ Less than typical |
About Verzenio: This medication is used to treat certain types of breast cancer. Show more ▾ Abemaciclib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. In 2023, this provider wrote 12 Medicare prescriptions for Verzenio, about 63% of the volume of the typical California prescriber of this medication (19). Medicare paid an average of $16,855.03 per fill, versus $14,260.97 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 336 Days of Medication total across all patients in 2023 | |||
| Escitalopram Oxalate | 11 | $3.85▼ below CA avg | ▼ Less than typical |
About Escitalopram Oxalate: Escitalopram is used to treat depression and anxiety. Show more ▾ It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. Escitalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRI). It may improve your energy level and feelings of well-being and decrease nervousness. S-enantiomer of CITALOPRAM. Belongs to a class of drugs known as SELECTIVE SEROTONIN REUPTAKE INHIBITORS, used to treat depression and generalized anxiety disorder. In 2023, this provider wrote 11 Medicare prescriptions for Escitalopram Oxalate, about a quarter of the volume of the typical California prescriber of this medication (47). Medicare paid an average of $3.85 per fill, versus $14.32 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for FARAH NASRATY is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this La Jolla, CA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among CA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
